| The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome O Amengual, T Atsumi, MA Khamashta, GRV Hughes Thrombosis and haemostasis 79 (02), 276-281, 1998 | 344 | 1998 |
| Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events K Otomo, T Atsumi, O Amengual, Y Fujieda, M Kato, K Oku, T Horita, ... Arthritis & Rheumatism 64 (2), 504-512, 2012 | 306 | 2012 |
| 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends ML Bertolaccini, O Amengual, L Andreoli, T Atsumi, CB Chighizola, ... Autoimmunity reviews 13 (9), 917-930, 2014 | 267 | 2014 |
| Complement activation in patients with primary antiphospholipid syndrome K Oku, T Atsumi, M Bohgaki, O Amengual, H Kataoka, T Horita, S Yasuda, ... Annals of the rheumatic diseases 68 (6), 1030-1035, 2009 | 263 | 2009 |
| Specificity of ELISA for antibody to β2-glycoprotein I in patients with antiphospholipid syndrome O Amengual, T Atsumi, MA Khamashta, T Koike, GRV Hughes Rheumatology 35 (12), 1239-1243, 1996 | 219 | 1996 |
| ‘Non-criteria’aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010 ML Bertolaccini, O Amengual, T Atsumi, WL Binder, B Laat, R Forastiero, ... Lupus 20 (2), 191-205, 2011 | 184 | 2011 |
| The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis T Kurita, S Yasuda, K Oba, T Odani, M Kono, K Otomo, Y Fujieda, K Oku, ... Rheumatology 54 (1), 39-44, 2015 | 157 | 2015 |
| Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role for endothelin 1 T Atsumi, MA Khamashta, RS Haworth, G Brooks, O Amengual, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1998 | 157 | 1998 |
| The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-β2Glycoprotein I antibodies M Bohgaki, T Atsumi, Y Yamashita, S Yasuda, Y Sakai, A Furusaki, ... International immunology 16 (11), 1633-1641, 2004 | 155 | 2004 |
| NFκB is an essential intermediate in the activation of endothelial cells by anti-β2-glycoprotein 1 antibodies S Dunoyer-Geindre, P de Moerloose, B Galve-de Rochemonteix, G Reber, ... Thrombosis and haemostasis 88 (11), 851-857, 2002 | 154 | 2002 |
| Elevated plasma lipoprotein (a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome. T Atsumi, MA Khamashta, C Andujar, MJ Leandro, O Amengual, PR Ames, ... The Journal of Rheumatology 25 (1), 69-73, 1998 | 111 | 1998 |
| Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus. ML Bertolaccini, T Atsumi, MA Khamashta, O Amengual, GR Hughes The Journal of rheumatology 25 (6), 1104-1108, 1998 | 103 | 1998 |
| Nicked β2-glycoprotein I: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis S Yasuda, T Atsumi, M Ieko, E Matsuura, K Kobayashi, J Inagaki, H Kato, ... Blood 103 (10), 3766-3772, 2004 | 96 | 2004 |
| Specificities, properties, and clinical significance of antiprothrombin antibodies O Amengual, T Atsumi, T Koike Arthritis & Rheumatism: Official Journal of the American College of …, 2003 | 95 | 2003 |
| Antiphospholipid antibody associated thrombocytopenia and the paradoxical risk of thrombosis T Atsumi, S Furukawa, O Amengual, T Koike Lupus 14 (7), 499-504, 2005 | 90 | 2005 |
| Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density … FI Romero, O Amengual, T Atsumi, MA Khamashta, FJ Tinahones, ... British journal of rheumatology 37 (8), 883-888, 1998 | 88 | 1998 |
| Binding of anticardiolipin antibodies to protein C via β2-glycoprotein I (β2-GPI): a possible mechanism in the inhibitory effect of antiphospholipid antibodies on the … T Atsumi, MA Khamashta, O Amengual, S Donohoe, I Mackie, K Ichikawa, ... Clinical & Experimental Immunology 112 (2), 325-333, 1998 | 84 | 1998 |
| Autoantibodies against oxidized low-density lipoprotein in antiphospholipid syndrome. O Amengual, T Atsumi, MA Khamashta, F Tinahones, GR Hughes British journal of rheumatology 36 (9), 964-968, 1997 | 83 | 1997 |
| Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome K Oku, O Amengual, T Atsumi European journal of clinical investigation 42 (10), 1126-1135, 2012 | 79 | 2012 |
| Correlation between β2-glycoprotein I valine/leucine247 polymorphism and anti-β2-glycoprotein I antibodies in patients with primary antiphospholipid syndrome T Atsumi, A Tsutsumi, O Amengual, MA Khamashta, GRV Hughes, ... Rheumatology 38 (8), 721-723, 1999 | 76 | 1999 |
Yuichiro Fujieda在 med.hokudai.ac.jp 的电子邮件经过验证
